3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
2
Phase 2
1
Status
Completed
3
Not yet recruiting
2
Unknown
1
Recruiting
1
Sponsor Class
OTHER
79
INDUSTRY
22
NIH
20
OTHER_GOV
3
NETWORK
1
Study Type
Interventional
3
Sponsor
Cancer Type
Dermatologic
3
Conditions
Breast Neoplasms
107
Neoplasms
80
Colorectal Neoplasms
54
Uterine Cervical Neoplasms
29
Stomach Neoplasms
29
Lung Neoplasms
27
Rectal Neoplasms
25
Prostatic Neoplasms
25
Colonic Neoplasms
24
Polycystic Ovary Syndrome
22
Pancreatic Neoplasms
22
Head and Neck Neoplasms
17
Endometrial Neoplasms
17
Carcinoma, Non-Small-Cell Lung
16
Carcinoma, Hepatocellular
16
Pain
15
Neoplasm Metastasis
15
Motor Activity
15
Esophageal Neoplasms
15
Ovarian Neoplasms
13
Urinary Bladder Neoplasms
11
Lymphoma
11
Precursor Cell Lymphoblastic Leukemia-Lymphoma
10
Pain, Postoperative
10
Melanoma
10
Thyroid Neoplasms
9
Pilonidal Sinus
9
Multiple Myeloma
9
Gastrointestinal Neoplasms
9
Sarcopenia
8
Interventions
pembrolizumab
1
entinostat
1
Nivolumab
1
Melphalan
1
Ipilimumab
1
Interleukin-2
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Completed
×
OTHER_GOV
×
Uveal Melanoma
×
Clear all
NCT04812470
2025-09-22
HAITILS
Vastra Gotaland Region
Phase 1
Completed
8 enrolled
NCT04463368
2025-03-28
SCANDIUM II
Vastra Gotaland Region
Phase 1
Completed
18 enrolled
NCT02697630
2023-12-08
PEMDAC
Vastra Gotaland Region
Phase 2
Completed
29 enrolled